A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
I8F-MC-GPGF - ClinicalTrials.gov - NCT03311724
The purpose of this study is to determine the efficacy of tirzepatide in participants with type 2 diabetes.
Trial Summary
Age Range
18 - 75 yearsConditions the trial is for
Type 2 DiabetesWhat the trial is testing?
TirzepatideCould I receive a Placebo?
YesEnrollment Goal
111Trial Dates
Oct 19, 2017 - Apr 24, 2018How long will I be in the trial?
Your participation could last approximately 12 weeks and include 9 visits to the study center.Trial Phase
IILilly Trial Alerts
Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.
You will complete the questionnaire on another website.YesNo